Cargando…
A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia
Autores principales: | Kohn, Milena, Delord, Marc, Chbat, Maureen, Guemriche, Amina, Merabet, Fatiha, Roupie, Anne-Laure, Lombion, Naelle, Farhat, Hassan, Longval, Thomas, Cabannes-Hamy, Aurélie, Lambert, Juliette, Marque-Juillet, Stéphanie, Raggueneau, Victoria, Osman, Jennifer, Spentchian, Marc, Rigaudeau, Sophie, Rousselot, Philippe, Besson, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152953/ https://www.ncbi.nlm.nih.gov/pubmed/34788987 http://dx.doi.org/10.3324/haematol.2021.280026 |
Ejemplares similares
-
A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients
por: Chbat, Maureen, et al.
Publicado: (2021) -
Antimongoloid as a pejorative term
por: Masukume, Gwinyai
Publicado: (2014) -
Pejorative Drift of Medical Words: Geriatric, Elitist
por: Baron, J H
Publicado: (1994) -
Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review
por: Traoré, Solo, et al.
Publicado: (2020) -
Chest computed tomography signs associated with pejorative evolution in COVID-19 patients
por: Auger, Romain, et al.
Publicado: (2021)